Cargando…

Identification of High-Risk of Recurrence in Clinical Stage I Non-Small Cell Lung Cancer

OBJECTIVE: This study aimed to identify patients at a high risk of recurrence using preoperative high-resolution computed tomography (HRCT) in clinical stage I non-small cell lung cancer (NSCLC). METHODS: A total of 567 patients who underwent screening and 1,216 who underwent external validation for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsutani, Yasuhiro, Shimada, Yoshihisa, Ito, Hiroyuki, Miyata, Yoshihiro, Ikeda, Norihiko, Nakayama, Haruhiko, Okada, Morihito
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215653/ https://www.ncbi.nlm.nih.gov/pubmed/34164334 http://dx.doi.org/10.3389/fonc.2021.622742

Ejemplares similares

Segmentectomy for clinically early‐stage primary squamous cell carcinoma of the lung
por: Kagimoto, Atsushi, et al.
Publicado: (2022)

Role of ground-glass opacity in pure invasive and lepidic component in pure solid lung adenocarcinoma for predicting aggressiveness
por: Mimae, Takahiro, et al.
Publicado: (2022)

Segmentectomy for cancer control in radiologically pure-solid clinical stage IA3 lung cancer
por: Kamigaichi, Atsushi, et al.
Publicado: (2023)

Wedge resection is an acceptable treatment option for radiologically low-grade lung cancer with solid predominance
por: Kamigaichi, Atsushi, et al.
Publicado: (2023)

Preoperative nivolumab to evaluate pathological response in patients with stage I non-small cell lung cancer: a study protocol of phase II trial (POTENTIAL)
por: Kagimoto, Atsushi, et al.
Publicado: (2021)

Transition of Treatment for Ground Glass Opacity–Dominant Non-Small Cell Lung Cancer
por: Handa, Yoshinori, et al.
Publicado: (2021)

Different significance of HRCT and FDG-PET/CT to predict lymph node status between patients with clinical stage IA lung adenocarcinoma and squamous cell carcinoma
por: Tsutani, Yasuhiro, et al.
Publicado: (2015)

Pathological high malignant grade is higher risk of recurrence in pN0M0 invasive lung adenocarcinoma, even with small invasive size
por: Ito, Masaoki, et al.
Publicado: (2021)

Extracellular vesicle-associated microRNA signatures related to lymphovascular invasion in early-stage lung adenocarcinoma
por: Shimada, Yoshihisa, et al.
Publicado: (2023)

Segmentectomy versus wedge resection for radiological solid predominant and low metabolic non-small cell lung cancer
por: Kagimoto, Atsushi, et al.
Publicado: (2022)

Preoperative predictors for recurrence sites associated with poor post-recurrence survival after surgery of non-small cell lung cancer: a multicenter study
por: Isaka, Tetsuya, et al.
Publicado: (2023)

Anatomical location and number of metastatic lymph nodes for prognosis of non-small cell lung cancer
por: Samejima, Joji, et al.
Publicado: (2021)

Wedge resection vs. segmentectomy for lung cancer measuring ≤ 2 cm with consolidation tumor ratio > 0.25
por: Isaka, Tetsuya, et al.
Publicado: (2023)

The intersegmental pulmonary vein is not always located on the intersegmental plane of the lung: Evaluation with 3-dimensional volume-rendering image reconstruction
por: Mimae, Takahiro, et al.
Publicado: (2022)

Association between [18F]-fluoro-2-deoxyglucose uptake and expressions of hypoxia-induced factor 1α and glucose transporter 1 in non-small cell lung cancer
por: Furukawa, Takaoki, et al.
Publicado: (2015)

Increased risk of recurrence in resected EGFR‐positive pN0M0 invasive lung adenocarcinoma
por: Ito, Masaoki, et al.
Publicado: (2018)

Segmentectomy for patients with early-stage pure-solid non-small cell lung cancer
por: Kamigaichi, Atsushi, et al.
Publicado: (2023)

Severity of lung fibrosis affects early surgical outcomes of lung cancer among patients with combined pulmonary fibrosis and emphysema
por: Mimae, Takahiro, et al.
Publicado: (2016)

Therapeutic strategies and genetic profile comparisons in small cell carcinoma and large cell neuroendocrine carcinoma of the lung using next-generation sequencing
por: Ito, Masaoki, et al.
Publicado: (2017)

Bronchial mucosal ablation for bronchial stump closure in right pneumonectomy: a case report
por: Makidono, Kimitaka, et al.
Publicado: (2021)

Application of PET/CT to adjuvant chemotherapy for early lung adenocarcinoma
por: Sasada, Shinsuke, et al.
Publicado: (2015)

The relationship between the malignancy grade of lung adenocarcinoma with micropapillary pattern and the findings of positron emission tomography
por: Tsubokawa, Norifumi, et al.
Publicado: (2015)

Interstitial pneumonia and advanced age negatively influence postoperative pulmonary function
por: Mimae, Takahiro, et al.
Publicado: (2022)

Multicenter phase II study on cisplatin, pemetrexed, and bevacizumab followed by maintenance with pemetrexed and bevacizumab for patients with advanced or recurrent nonsquamous non-small cell lung cancer: MAP study
por: Tsutani, Yasuhiro, et al.
Publicado: (2018)

Metabolomic analysis of dynamic response and drug resistance of gastric cancer cells to 5-fluorouracil
por: SASADA, SHINSUKE, et al.
Publicado: (2012)

Impact of postoperative pleurodesis on pulmonary function after lung segmentectomy
por: Kagimoto, Atsushi, et al.
Publicado: (2020)

The safety and efficacy of fibrinogen and thrombin-based collagen fleece for treatment of pleural injury
por: Tsubokawa, Norifumi, et al.
Publicado: (2015)

Serum S100 calcium-binding protein A4 as a novel predictive marker of acute exacerbation of interstitial pneumonia after surgery for lung cancer
por: Kagimoto, Atsushi, et al.
Publicado: (2021)

Usefulness of serum S100A4 and positron‐emission tomography on lung cancer accompanied by interstitial pneumonia
por: Kagimoto, Atsushi, et al.
Publicado: (2022)

Completion lobectomy for unanticipated pN1 disease on postoperative pathology after segmentectomy for cT1N0 lung cancer: Prevention of pleural adhesion by using fibrin glue
por: Miyata, Yoshihiro, et al.
Publicado: (2015)

Current clinical trials with non-coding RNA-based therapeutics in malignant diseases: A systematic review
por: Ito, Masaoki, et al.
Publicado: (2023)

Utility of Newly Proposed Grading System From International Association for the Study of Lung Cancer for Invasive Lung Adenocarcinoma
por: Kagimoto, Atsushi, et al.
Publicado: (2020)

Concurrent Nivolumab-Induced Gastritis and Cholangitis Accompanied by Biliary Tract Hemorrhage in a Patient With Stage IV Lung Adenocarcinoma
por: Tsukaguchi, Akihiro, et al.
Publicado: (2023)

Glypican-1 is a novel immunohistochemical marker to differentiate poorly differentiated squamous cell carcinoma from solid predominant adenocarcinoma of the lung
por: Kai, Yuichiro, et al.
Publicado: (2021)

Prognostic impact of vascular invasion and standardization of its evaluation in stage I non-small cell lung cancer
por: Hamanaka, Rurika, et al.
Publicado: (2015)

Real-world clinical outcomes of nivolumab and taxane as a second- or later-line therapy for recurrent or unresectable advanced esophageal squamous cell carcinoma
por: Ohsawa, Manato, et al.
Publicado: (2023)

Circulating microRNA/isomiRs as novel biomarkers of esophageal squamous cell carcinoma
por: Ibuki, Yuta, et al.
Publicado: (2020)

Identification of Prognostic Model Based on Immune-Related LncRNAs in Stage I-III Non-Small Cell Lung Cancer
por: Li, Qiaxuan, et al.
Publicado: (2021)

Distribution and prognostic impact of EGFR and KRAS mutations according to histological subtype and tumor invasion status in pTis-3N0M0 lung adenocarcinoma
por: Ito, Masaoki, et al.
Publicado: (2023)

Enhanced gefitinib‐induced repression of the epidermal growth factor receptor pathway by ataxia telangiectasia‐mutated kinase inhibition in non‐small‐cell lung cancer cells
por: Misumi, Keizo, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_1ubhhgt078gpun2v1spfgupmae